Charles River Laboratories Gross Margin 2010-2025 | CRL

Charles River Laboratories gross margin for the quarter ending March 31, 2025 was 32.44%.

  • Charles River Laboratories average gross margin for 2024 was 34.59%, a 5.65% decline from 2023.
  • Charles River Laboratories average gross margin for 2023 was 36.66%, a 1.61% decline from 2022.
  • Charles River Laboratories average gross margin for 2022 was 37.26%, a 0.75% decline from 2021.

Gross margin can be defined as a company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage.

Charles River Laboratories Gross Margin 2010-2025 | CRL

  • Charles River Laboratories average gross margin for 2024 was 34.59%, a 5.65% decline from 2023.
  • Charles River Laboratories average gross margin for 2023 was 36.66%, a 1.61% decline from 2022.
  • Charles River Laboratories average gross margin for 2022 was 37.26%, a 0.75% decline from 2021.

Gross margin can be defined as a company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage.
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$138.3B
CVS Health (CVS)$80.7B
Elevance Health (ELV)$77.8B
Cencora (COR)$57.7B
DiDi Global (DIDIY)$28.9B
Labcorp Holdings (LH)$20.6B
Natera (NTRA)$20.3B
BioMerieux (BMXMF)$16.9B
EUROFINS SCIENT (ERFSF)$13.9B
CochLear (CHEOY)$12.8B
Solventum (SOLV)$12.6B
ICON (ICLR)$11.6B
Revvity (RVTY)$11.2B
Viatris (VTRS)$10.7B
Medpace Holdings (MEDP)$9B
Sonic Healthcare (SKHHY)$8.8B
Avantor (AVTR)$8.8B
HealthEquity (HQY)$8.4B
Caris Life Sciences,�Inc (CAI)$8B
Amplifon S.p.A (AMFPF)$5.4B
Bausch + Lomb (BLCO)$4.9B
BrightSpring Health Services (BTSG)$3.5B
Sotera Health (SHC)$3.2B
Surgery Partners (SGRY)$2.9B
Alignment Healthcare (ALHC)$2.6B
Concentras Parent (CON)$2.5B
Organon (OGN)$2.5B
GeneDx Holdings (WGS)$2.3B
Progyny (PGNY)$2B
PACS (PACS)$1.9B